Zy 15109

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 597255

CAS#: 113701-65-8

Description: Zy 15109 is an inhaled mast cell stabiliser.

Chemical Structure

Zy 15109
CAS# 113701-65-8

Theoretical Analysis

MedKoo Cat#: 597255
Name: Zy 15109
CAS#: 113701-65-8
Chemical Formula: C11H15MgN2O8
Exact Mass:
Molecular Weight: 327.55
Elemental Analysis: C, 40.34; H, 4.62; Mg, 7.42; N, 8.55; O, 39.08

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Zy 15109; Zy-15109; Zy15109; N-Acetyl-aspartyl magnesium glutamate; Magnesium N-acetyl-aspartylglutamate;

IUPAC/Chemical Name: monomagnesium mono((S)-2-((S)-2-acetamido-3-carboxypropanamido)-4-carboxybutanoate)


InChi Code: InChI=1S/C11H16N2O8.Mg/c1-5(14)12-7(4-9(17)18)10(19)13-6(11(20)21)2-3-8(15)16;/h6-7H,2-4H2,1H3,(H,12,14)(H,13,19)(H,15,16)(H,17,18)(H,20,21);/q;+2/p-1/t6-,7-;/m0./s1

SMILES Code: O=C(O)CC[C@@H](C([O-])=O)NC([C@H](CC(O)=O)NC(C)=O)=O.[Mg+2]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

Preparing Stock Solutions

The following data is based on the product molecular weight 327.55 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Miyamoto Y, Iegaki N, Fu K, Ishikawa Y, Sumi K, Azuma S, Uno K, Muramatsu SI, Nitta A. Striatal N-Acetylaspartate Synthetase Shati/Nat8l Regulates Depression-Like Behaviors via mGluR3-Mediated Serotonergic Suppression in Mice. Int J Neuropsychopharmacol. 2017 Dec 1;20(12):1027-1035. doi: 10.1093/ijnp/pyx078. PubMed PMID: 29020418; PubMed Central PMCID: PMC5716104.

2: Swann JR, Garcia-Perez I, Braniste V, Wilson ID, Sidaway JE, Nicholson JK, Pettersson S, Holmes E. Application of (1)H NMR spectroscopy to the metabolic phenotyping of rodent brain extracts: A metabonomic study of gut microbial influence on host brain metabolism. J Pharm Biomed Anal. 2017 Sep 5;143:141-146. doi: 10.1016/j.jpba.2017.05.040. Epub 2017 May 31. PubMed PMID: 28595107.

3: Zhu H, Lai M, Chen W, Mei D, Zhang F, Liu H, Zhou W. N-acetylaspartylglutamate Inhibits Heroin Self-Administration and Heroin-Seeking Behaviors Induced by Cue or Priming in Rats. Neurosci Bull. 2017 Aug;33(4):396-404. doi: 10.1007/s12264-017-0140-3. Epub 2017 May 22. PubMed PMID: 28534263; PubMed Central PMCID: PMC5567560.

4: Rosa CE, Soares JC, Figueiredo FP, Cavalli RC, Barbieri MA, Schaufelberger MS, Salmon CEG, Del-Ben CM, Santos AC. Glutamatergic and neural dysfunction in postpartum depression using magnetic resonance spectroscopy. Psychiatry Res Neuroimaging. 2017 Jul 30;265:18-25. doi: 10.1016/j.pscychresns.2017.04.008. Epub 2017 Apr 26. PubMed PMID: 28494346.

5: Marjańska M, McCarten JR, Hodges J, Hemmy LS, Grant A, Deelchand DK, Terpstra M. Region-specific aging of the human brain as evidenced by neurochemical profiles measured noninvasively in the posterior cingulate cortex and the occipital lobe using (1)H magnetic resonance spectroscopy at 7 T. Neuroscience. 2017 Jun 23;354:168-177. doi: 10.1016/j.neuroscience.2017.04.035. Epub 2017 May 3. PubMed PMID: 28476320; PubMed Central PMCID: PMC5516630.

6: Chan KL, Saleh MG, Oeltzschner G, Barker PB, Edden RAE. Simultaneous measurement of Aspartate, NAA, and NAAG using HERMES spectral editing at 3 Tesla. Neuroimage. 2017 Jul 15;155:587-593. doi: 10.1016/j.neuroimage.2017.04.043. Epub 2017 Apr 21. PubMed PMID: 28438664; PubMed Central PMCID: PMC5511573.

7: Bond DJ, Silveira LE, MacMillan EL, Torres IJ, Lang DJ, Su W, Honer WG, Lam RW, Yatham LN. Diagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder. Transl Psychiatry. 2017 Mar 28;7(3):e1071. doi: 10.1038/tp.2017.42. PubMed PMID: 28350397; PubMed Central PMCID: PMC5404613.

8: Hicks C, Gregg RA, Nayak SU, Cannella LA, Schena GJ, Tallarida CS, Reitz AB, Smith GR, Rawls SM. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG). Psychopharmacology (Berl). 2017 Jun;234(11):1671-1681. doi: 10.1007/s00213-017-4568-y. Epub 2017 Mar 1. PubMed PMID: 28251297; PubMed Central PMCID: PMC5433920.

9: Benito-León J, Louis ED, Mato-Abad V, Dydak U, Álvarez-Linera J, Hernández-Tamames JA, Molina-Arjona JA, Malpica N, Matarazzo M, Romero JP, Sánchez-Ferro Á. In vivo neurometabolic profiling in orthostatic tremor. Medicine (Baltimore). 2016 Sep;95(37):e4848. doi: 10.1097/MD.0000000000004848. PubMed PMID: 27631243; PubMed Central PMCID: PMC5402586.

10: Baslow MH. Is the tri-cellular N-acetylaspartylglutamate (NAAG) cycle related to the etiology of schizophrenia? Schizophr Res. 2016 Dec;178(1-3):112-113. doi: 10.1016/j.schres.2016.09.009. Epub 2016 Sep 7. PubMed PMID: 27613510.

11: Rosewich H, Dechent P, Krause C, Ohlenbusch A, Brockmann K, Gärtner J. Diagnostic and prognostic value of in vivo proton MR spectroscopy for Zellweger syndrome spectrum patients. J Inherit Metab Dis. 2016 Nov;39(6):869-876. Epub 2016 Aug 3. PubMed PMID: 27488561.

12: Bairwa D, Kumar V, Vyas S, Das BK, Srivastava AK, Pandey RM, Sharma SK, Jagannathan NR, Sinha S. Case control study: magnetic resonance spectroscopy of brain in HIV infected patients. BMC Neurol. 2016 Jul 12;16:99. doi: 10.1186/s12883-016-0628-x. PubMed PMID: 27405321; PubMed Central PMCID: PMC4942893.

13: Conway RE, Rojas C, Alt J, Nováková Z, Richardson SM, Rodrick TC, Fuentes JL, Richardson NH, Attalla J, Stewart S, Fahmy B, Barinka C, Ghosh M, Shapiro LH, Slusher BS. Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide. Angiogenesis. 2016 Oct;19(4):487-500. doi: 10.1007/s10456-016-9521-x. Epub 2016 Jul 8. PubMed PMID: 27387982.

14: Khacho P, Wang B, Bergeron R. The Good and Bad Sides of NAAG. Adv Pharmacol. 2016;76:311-49. doi: 10.1016/bs.apha.2016.01.003. Epub 2016 Mar 2. Review. PubMed PMID: 27288081.

15: Vornov JJ, Hollinger KR, Jackson PF, Wozniak KM, Farah MH, Majer P, Rais R, Slusher BS. Still NAAG'ing After All These Years: The Continuing Pursuit of GCPII Inhibitors. Adv Pharmacol. 2016;76:215-55. doi: 10.1016/bs.apha.2016.01.007. Epub 2016 Mar 18. Review. PubMed PMID: 27288079.

16: Liu Q, Ye Q. Computationally Prediction of Candidate Agents for Preventing Organ Dysfunction After Brain Death. Ann Transplant. 2016 May 12;21:301-10. PubMed PMID: 27170053.

17: Chan KL, Puts NA, Schär M, Barker PB, Edden RA. HERMES: Hadamard encoding and reconstruction of MEGA-edited spectroscopy. Magn Reson Med. 2016 Jul;76(1):11-9. doi: 10.1002/mrm.26233. Epub 2016 Apr 19. PubMed PMID: 27089868; PubMed Central PMCID: PMC5385137.

18: Brandt AS, Unschuld PG, Pradhan S, Lim IA, Churchill G, Harris AD, Hua J, Barker PB, Ross CA, van Zijl PC, Edden RA, Margolis RL. Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla. Schizophr Res. 2016 Apr;172(1-3):101-5. doi: 10.1016/j.schres.2016.02.017. Epub 2016 Feb 28. PubMed PMID: 26925800; PubMed Central PMCID: PMC4821673.

19: Garg R, Brennan L, Price RK, Wallace JM, Strain JJ, Gibney MJ, Shewry PR, Ward JL, Garg L, Welch RW. Using NMR-Based Metabolomics to Evaluate Postprandial Urinary Responses Following Consumption of Minimally Processed Wheat Bran or Wheat Aleurone by Men and Women. Nutrients. 2016 Feb 17;8(2):96. doi: 10.3390/nu8020096. PubMed PMID: 26901221; PubMed Central PMCID: PMC4772058.

20: Hollinger KR, Alt J, Riehm AM, Slusher BS, Kaplin AI. Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis. Brain Res. 2016 Mar 15;1635:105-12. doi: 10.1016/j.brainres.2016.01.035. Epub 2016 Jan 26. PubMed PMID: 26826008.